Simeprevir (Olysio®)
NICE TA 331. NHSE clinical commissioning policy statement: Treatment of chronic hepatitis C in patients with cirrhosis
-
Traffic LightRed
-
BNF5.3.3.2
-
Licensed IndicatorsIn combination with peginterferon alfa and ribavirin for treating genotypes 1 and 4 chronic hepatitis C
-
ReferenceAPC July 14 , May 15, Sep 15
-
ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?